3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Status
Completed
3
Unknown
1
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Other hematologic neoplasm
1
Other
1
Myeloid
1
Gynecologic
1
Gastrointestinal
1
Conditions
Weight Loss
1
Preleukemia
1
Ovarian Neoplasms
1
Obesity
1
Myelodysplastic Syndromes
1
Malnutrition
1
Gastrointestinal Neoplasms
1
Endometrial Neoplasms
1
Interventions
Cyclophosphamide
955
Radiotherapy
847
Cisplatin
756
Gemcitabine
657
Carboplatin
602
Docetaxel
598
Paclitaxel
585
Bevacizumab
579
Fluorouracil
504
Oxaliplatin
458
Rituximab
453
Surveys and Questionnaires
449
Capecitabine
440
Dexamethasone
428
Doxorubicin
423
Etoposide
410
Irinotecan
389
Cytarabine
376
Filgrastim
369
pembrolizumab
327
Leucovorin
305
Nivolumab
295
fludarabine phosphate
294
Melphalan
288
Magnetic Resonance Spectroscopy
280
Blood Specimen Collection
279
Peripheral Blood Stem Cell Transplantation
278
Methotrexate
276
Lenalidomide
276
Cetuximab
269
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Completed
×
OTHER
×
Sampling Studies
×
Clear all
NCT02573974
2025-12-22
METERMUCADIG
University Hospital, Tours
Phase NA
Completed
51 enrolled
NCT03027479
2025-12-22
METERMUS-IMC
University Hospital, Tours
Phase NA
Completed
70 enrolled
NCT02809222
2021-04-19
PLASMYC
University Hospital, Tours
Phase NA
Completed
138 enrolled